FTSE MIB
33.420,20 -534,08 (-1,57%) Dow Jones
37.735,11 -248,13 (-0,65%) Nasdaq
15.885,02 -290,08 (-1,79%) Nikkei 225
38.471,20 -761,60 (-1,94%) Petrolio
85,58 +0,17 (+0,20%) Bitcoin EUR
59.833,89 -2.675,08 (-4,28%)
ResMed Inc. (RMD)
Dopo ore:
| Chiusura precedente | 185,86 |
| Aperto | 187,95 |
| Denaro | 0,00 x 800 |
| Lettera | 0,00 x 1000 |
| Min-Max giorno | 184,78 - 189,29 |
| Intervallo di 52 settimane | 132,24 - 243,52 |
| Volume | |
| Media Volume | 1.002.327 |
| Capitalizzazione | 27,225B |
| Beta (5 anni mensile) | 0,67 |
| Rapporto PE (ttm) | 30,69 |
| EPS (ttm) | 6,03 |
| Prossima data utili | 25 apr 2024 |
| Rendimento e dividendo (futuro) | 1,92 (1,04%) |
| Data ex dividendo | 07 feb 2024 |
| Stima target 1A | 202,68 |
GlobeNewswireResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2024 on Thursday, October 26, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: •Location:http://investor.resmed.com•Date
- GlobeNewswire
ResMed Announces Participation in Upcoming Conferences
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced its participation in two upcoming conferences. Mick Farrell, chief executive officer and chair of the board, and Brett Sandercock, chief financial officer, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, September 12, 2023, beginning at approximately 10:50 a.m. (Eastern Daylight Time) at the Sheraton New York Times Square in New York, NY. Rob D
- GlobeNewswire
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
Year-over-year revenue grows 23%, operating profit up 8%, non-GAAP operating profit up 13%Quarterly dividend increases 9% to $0.48 per share Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2023. Fourth Quarter 2023 HighlightsAll comparisons are to the prior year period Revenue increased by 23% to $1
